Trump Plans Pharma Tariffs To Spur U.S. Manufacturing, Experts Warn Of Price Hikes And Supply Risks

President Trump said he plans to announce tariffs on pharmaceuticals to encourage drug companies to return manufacturing to the U.S., according to ABC News. He claimed the U.S. market's size would drive companies to leave countries like China and reopen plants domestically. Most drug ingredients are made overseas, and tariffs could raise the cost of medications. Experts warned that pharmaceutical tariffs could cause drug shortages and hinder research and development.